Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Buy
14,100
+2,800
+25% +$46.6K ﹤0.01% 9960
2025
Q4
$204K Sell
11,300
-23,900
-68% -$411K ﹤0.01% 9688
2025
Q3
$567K Buy
+35,200
New +$515K ﹤0.01% 7588
2020
Q4
Sell
-80,800
Closed -$2.94M 7855
2020
Q3
$2.94M Buy
80,800
+38,600
+91% +$1.21M ﹤0.01% 2470
2020
Q2
$947K Buy
+42,200
New +$903K ﹤0.01% 4139

Other funds holding MESO

Jane Street's MESO Position: Q1 2026 in Review

Jane Street reduced its Mesoblast (MESO) stake by 41% in Q1 2026, selling an estimated $1.14M and leaving 98,786 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #5614.

Jane Street first reported a position in MESO in Q1 2016 and has held it in 27 quarters since. The position peaked at $3.02M in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Jane Street held 98,786 shares of Mesoblast worth $1.52M as of Q1 2026.
  • Jane Street sold 68,594 Mesoblast shares in Q1 2026, an estimated $1.14M.
  • Mesoblast made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5614 holding.
  • Jane Street first reported a position in Mesoblast in Q1 2016 and has held it in 27 quarters since.
  • Jane Street's Mesoblast position peaked at $3.02M in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.